Olive Oil and Cardiovascular Risk: The Higher the Consumption, the Lower the Risk?

High olive oil intake was associated with lower risk of coronary heart disease and cardiovascular disease in two large prospective cohorts of men and women.

Aceite de oliva y riesgo cardiovascular ¿A mayor consumo menos enfermedad?

The substitution of margarine, butter, mayonnaise, and dairy fat with olive oil can have a significant impact on cardiovascular health.

The benefits of olive oil intake have been well studied in Mediterranean populations. However, two factors should be considered: first, besides olive oil, that population consumes a whole combination of foods with cardiovascular benefit (a Mediterranean diet); second, the Mediterranean region is the main producer of olive oil and many feared a conflict of interests.

In that sense, we wondered about the effectiveness of this product in populations in other corners of the world.


Read also: Is There a “Safe” Dose for Meat Consumption?


This study assessed the eventual benefit of olive oil intake as regards overall cardiovascular disease, coronary heart disease, and stroke risk in an American population.

This study included 61,181 women and 31,797 men from 1990 to 2014 who were free of cancer, heart disease, and stroke at baseline. Diet was assessed through questionnaires at baseline and then every 4 years.

After 24 years of follow-up, adjusting for other risk factors, high olive oil intake (>0.5 tablespoon/day or >7 g/day) reduced the overall cardiovascular risk by 14% (hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.79 to 0.94) and the coronary heart disease risk by 18% (HR: 0.82; 95% CI: 0.73 to 0.91), while there were no significant associations for total or ischemic stroke.


Read also: ACC Recommendations against the New Coronavirus.


Replacing 5 g/day of margarine, butter, mayonnaise, or dairy fat with the equivalent amount of olive oil reduces the total cardiovascular risk and the coronary heart disease risk by 5% to 7%.

The subset of participants with higher olive oil intake showed lower levels of circulating inflammatory biomarkers and a better lipid profile.

Conclusion

High olive oil intake was associated with a reduction in the risk of total cardiovascular and coronary heart disease. The substitution of margarine, butter, mayonnaise, and dairy fat with olive oil can have a clear benefit for cardiovascular health.

Título original: Olive Oil Consumption and Cardiovascular Risk in U.S. Adults.

Referencia: Marta Guasch-Ferré et al. Journal of the American College of Cardiology 2020, Journal Pre-proof. https://doi.org/10.1016/j.jacc.2020.02.036.


[wysija_form id=”3″]

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...